ALEMBIC PHARMACEUTICALS LTD. - Alembic Pharmaceuticals Limited Passes ANVISA (Brazil) GMP Audit For Its API-III Facility At Karakhadi

We would like to inform the exchange that the Company has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-III Facilty at Karakhadi without any observations for its 56 APIs. The inspection was conducted from 20th March, 2023 to 24th March, 2023.